PGT-A
Preimplantation Genetic Testing for Aneuploidy (PGT-A) is a procedure used during in vitro fertilization (IVF) to screen embryos for chromosomal abnormalities before implantation.
About PGT-A
PGT-A or preimplantation genetic testing for aneuploidy, is a procedure used to screen embryos for chromosomal abnormalities during in vitro fertilization (IVF) before implantation, in order to increase the chances of a successful pregnancy.
PGT-A detects:
- Aneuploidies
- Partial (segmental) aneuploidies
- Unbalanced translocations
- Some types of polyploidy
- Mosaicism
Many factors can affect the course of pregnancy, but chromosomal abnormalities are the most common cause of adverse outcomes.
38%–76%
Prevalence of chromosomal abnormalities detected in spontaneous miscarriages, according to global and Russian statistics.
How to take the test
You can take the test at our collection point at:
Tashkent, 1st Rakatboshi passage, 17
Blood collection takes no more than 10 minutes. Results are available online or in print.
Preimplantation Genetic Testing for Aneuploidy (PGT-A) in the Genscreen Laboratory
International experience
Experts with years of practice in genetics, laboratory diagnostics and bioinformatics.
Confidentiality guarantee
We strictly follow the privacy policy: information is not shared with third parties without consent.
Personal consultation
Online consultation is available to explain results after the study.
Reliability and control
Every research stage is under strict supervision and multiple checks.
Technological leadership
Modern equipment and international diagnostic standards.
Transparent pricing
Clear costs without hidden fees, with the option to choose the most suitable test.